A. G. Chuchalin (Moscow, Russia), P. Bresser (Amsterdam, The Netherlands)
Prognosis of pulmonary Langerhans' cell granulomatosis
Z. Z. Pavlovic-Popovic, B. D. Djuric, O. K. Maksimovic, S. M. Kasikovic-Lecic (Sremska Kamenica, Yugoslavia)
|  |
Pulmonary langerhans¢ cell histiocytosis (LCH) - a retrospective review of 17 patients
M. Sobiecka, S. Wesolowski, M. Korzeniewska-Kosela, R. Langfort, I. Bestry, J. Kus (Warsaw, Poland)
| |
Diagnosis of Langergans' cell histiocytosis (retrospective analysis of 70 cases)
O. P. Baranova, M. M. Ilkovitch, E. M. Dembo-Smeathon, I. V. Dvorakovskaya, V. A. Amosov, N. G. Yakovleva (St Petersburg, Russia)
| |
Evaluation of HRCT, pulmonary function tests, alveolar-arterial oxygen tension gradient, DLCO in patients with chronic HCV infection
A. N. Tokgonul, A. Erturk, N. Capan, H. Erturk, V. Alaoglu, B. Dursun, H. Bozkaya (Ankara, Turkey)
| |
Simultaneous existence of diffuse alveolar damage and subpleural limited usual interstitial pneumonia lesion ( focal-UIP ) in clinical acute interstitial pneumonia
J. Araya, Y. Kawabata, P. Jinho, Y. Sugita, H. Ogata, T. Uchiyama, M. Kobayashi (Osatogun, Japan)
| |
Idiopathic Interstitial pneumonia: case series report
M. E. Yrigoyen, J. Somocursio, E. Martinez, A. V. Hernández (Lima, Peru)
| |
Fatal interstitial pneumonitis in a patient treated with pegylated interferon alpha-2b and ribavirin for hepatitis C infection
V. H. Fuhrmann, L. Kramer, E. Bauer, G. Tucek, G. Laferl, G. Dekan, P. Schenk (Vienna, Austria)
| |
Treatment of Idiopathic pulmonary fibrosis with interferon beta - our experience in seven patients
A. E. Buker, L. Jamieson, C. Gutierrez, C. K. Chan (Toronto, Canada)
| |
Mesalazine alveolitis in a patient with ulcerative colitis
A. Antoniadis, G. Pitsiou, T. Hatziandreou, D. Bobotas, E. Fouka, A. Kosma, M. Saroglou, N. Galanis (Thessaloniki, Greece)
| |
Idiopathic pulmonary alveolar proteinosis: GM CSF therapy and whole lung lavage a case report
E. Gingrich, V. Havranek, F. Wantke, I. Herkner, P. Errhalt, F. Kummer, K. Nakata (Vienna, Austria; Tokyo, Japan)
| |
Relationship between six-minute walk test and resting lung function in patients with IPF
S. Wesolowski, M. Franczuk, P. Boros, M. Kram, J. Kus (Warsaw, Poland)
| |
Alveolar proteinosis, reccurrent VZV infection, TB lymphadenitis and Aspergillus fumigatus arthritis in idiapathic CD4 T lymphocytopenia: A case report
S. M. Mirsaeidi, M. Amiri, H. Jamaati, S. D. Mansouri, S. Shahghasempour, M. R. Masjedi (Tehran, Iran)
| |
Prognosis of pulmonary sarcoidosis in young patients
Z. Z. Pavlovic-Popovic, B. D. Djuric, O. K. Maksimovic, S. M. Kasikovic-Lecic (Sremska Kamenica, Yugoslavia)
| |
Prognostic predictors of course sarcoidosis
O. S. Tolokh (Lviv, Ukraine)
| |
Value of serum angiotensin converting enzyme (SACE) level in the assessment of lung parenchyma impairment in newly diagnosed sarcoidosis
L. I. Cervis, C. Teleaga, D. Ionita, R. Nemes, N. Bisca, A. Serbescu (Bucharest, Romania)
| |
Prognostic factors in sarcoidosis: influence of SACE, HRCT scan, extrapulmonary presentation and steroid tratment
C. Vilariño, A. Baloira (Pontevedra, Spain)
| |
The prognostic significance of different clinical, radiological and laboratory parameters in sarcoidosis
A. Krychniak-Soszka, S. Wedzicha, J. Kus, A. Jozwik (Warsaw, Poland)
| |
Diagnostic delay in sarcoidosis
C. Cilt, D. Ionita, I. P. Stoicescu (Bucharest, Romania)
| |
Serum cytokine and antiviral antibody in the clinical course of sarcoidosis
T. Tachibana, H. Okamura, K. Yamanishi (Suita, Nishinomiya, Japan)
| |
QT dispersion in sarcoidosis
E. J. Csanky, A. Vasko, I. Hegedus, I. Lorincz (Debrecen, Hungary)
| |